Red Sox trade John Lackey to Cardinals for Allen Craig and Joe Kelly


Not satisfied with adding Justin Masterson to the rotation yesterday, the Cardinals have added another veteran starter by acquiring John Lackey from the Red Sox. And, much like Boston’s deal to get Yoenis Cespedes from Oakland for Jon Lester, the Red Sox have prioritized the present by getting veterans Allen Craig and Joe Kelly in exchange.

[MORE: Trade deadline tracker]

Not only has Lackey bounced back from a lost 2012 season with two consecutive solid years as a mid-rotation starter in Boston–posting a 3.55 ERA in 50 total starts since last season–he’s under contract for 2015 at the bargain price of $500,000 thanks to an odd wrinkle in his original deal with the Red Sox.

In return the Red Sox get a rotation replacement for Lackey in the 26-year-old Kelly, who has a 3.25 ERA in 38 career starts. However, his modest 6.5 strikeouts per nine innings in the National League are reason for skepticism that he’ll thrive long term, especially in the American League.

[MORE: Breaking down the Jon Lester-Yoenis Cespedes trade]

Craig had three straight excellent seasons for the Cardinals, hitting a combined .312 with an .863 OPS in 328 games from 2011-2013, but he’s collapsed this year at age 29 with a .638 OPS and has three years and $25 million left on his contract. St. Louis has stud prospect Oscar Taveras ready to replace Craig in the outfield and in the lineup.

Boston is betting on a big bounceback from Craig and Kelly’s ability to step into Lackey’s rotation spot with similar results. St. Louis is betting on Taveras developing into a star, Lackey being better than Kelly for the next one-and-a-half seasons, and Craig staying on the decline heading into his thirties. It’s a helluva interesting deal.

Jorge Polanco suspended 80 games after testing positive for Stanozolol

Brian Blanco/Getty Images
Leave a comment’s Rhett Bollinger reports that Twins shortstop Jorge Polanco has been suspended 80 games after testing positive for the performance-enhancing drug Stanozolol.

In a statement, via Dan Hayes of The Athletic, Polanco denied knowingly using the substance. Polanco said, “To be clear, I did not intentionally consume this steroid. I now know, however, that my intention alone is not a good enough excuse and I will pay the price for my error in judgment. The substance that I requested from my athletic trainer in the Dominican Republic and consented to take was a combination of vitamin B12 and an iron supplement, something that is not unusual or illegal for professional athletes to take. Unfortunately, what I was given was not that supplement and I take full responsibility for what is in my body.”

Last year was Polanco’s first full season in the majors. He hit .256/.313/.410 with 13 home runs, 74 RBI, 60 runs scored, and 13 stolen bases in 544 plate appearances.

The Twins have Ehire Adrianza and Erick Aybar to handle shortstop while Polanco is out. The club could also give the starting job to prospect Nick Gordon, ranked No. 4 in the Twins’ system according to MLB Pipeline. Gordon had a solid 2017 campaign at Double-A Chattanooga, posting a .749 OPS with 29 doubles and 13 steals in 578 PA.